![Turki Almaslokh](https://profiles-cardiff.imgix.net/attachments/7774?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Mr Turki Almaslokh
Teams and roles for Turki Almaslokh
Research student
Overview
Working on:
Investigating the risk factors, mechanism, and clinical biomarkers associted with Hydroxychloroquine (HCQ) retinal toxicity by using multimodal imaging and functional assessments including the Multifocal electroretinogram, Swept-source optical coherance tomography, Optical coherance tomography angiography, and Retinal imaging densitometry.
Experiance :
- Lecturer & Optometrist (2019-Present): KSU, Riyadh, Saudi Arabia.
- Optometrist (2018-2022): Private Eye Clinical Center.
Qualifications:
- PhD (2024-Present): Retinal dosorders: Cardiff University, Cardiff, UK.
- Fellowship (2023-2024): Educational Fellowship: Cardiff University, Cardiff, UK.
- Msc:(2022-2023): Clinical Optometry: Cardiff University, Cardiff, UK.
- Myopia Control: Certified Myopia Control Managment (MYLO)
- Bsc: (2013-2017): Optometry Doctor: King Saud University (KSU), Riyadh, Saudi Arabia.
Research
Interested in: Retinal health research.
A dedicated researcher specialising in the field of retinal disorders with a keen interest in understanding the complexities of retinal health. The current research focuses on investigating the effect of long-term use of Hydroxychloroquine (HCQ) on retinal health. This research aims to uncover the potential impacts of this drug on the retina, contributing to improved patient care and safety. The work is driven by a passion for advancing knowledge in retinal health and developing strategies to mitigate drug-induced retinal toxicity.
